Cabot (NYSE:CBT) Releases FY 2026 Earnings Guidance

Cabot (NYSE:CBT) issued an update on its FY 2026 earnings guidance on Tuesday morning. The company provided EPS guidance of 6.000-6.500 for the period, compared to the consensus EPS estimate of 6.530. The company issued revenue guidance of -.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on CBT. UBS Group raised their target price on Cabot from $74.00 to $81.00 and gave the company a “neutral” rating in a research note on Thursday. JPMorgan Chase & Co. cut their price objective on shares of Cabot from $75.00 to $54.00 and set an “underweight” rating on the stock in a research report on Friday, November 28th. Zacks Research raised shares of Cabot from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 27th. Jefferies Financial Group restated a “buy” rating and issued a $85.00 target price on shares of Cabot in a research report on Wednesday. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Cabot in a report on Monday, December 29th. One research analyst has rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $73.75.

Cabot Price Performance

Cabot stock traded down $3.08 during trading hours on Thursday, hitting $75.65. 235,906 shares of the company traded hands, compared to its average volume of 492,088. Cabot has a 1-year low of $58.33 and a 1-year high of $89.15. The firm has a market cap of $4.00 billion, a P/E ratio of 13.28, a P/E/G ratio of 3.73 and a beta of 0.88. The firm’s 50-day simple moving average is $68.79 and its two-hundred day simple moving average is $71.66. The company has a quick ratio of 1.08, a current ratio of 1.61 and a debt-to-equity ratio of 0.50.

Cabot (NYSE:CBT) last posted its quarterly earnings data on Tuesday, February 3rd. The specialty chemicals company reported $1.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.13. Cabot had a net margin of 8.62% and a return on equity of 23.06%. The business had revenue of $849.00 million during the quarter, compared to analysts’ expectations of $889.11 million. During the same period last year, the firm posted $1.76 earnings per share. The business’s revenue was down 11.1% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.000-6.500 EPS. As a group, analysts forecast that Cabot will post 7.57 earnings per share for the current fiscal year.

Cabot Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, March 13th. Stockholders of record on Friday, February 27th will be given a dividend of $0.45 per share. The ex-dividend date is Friday, February 27th. This represents a $1.80 annualized dividend and a dividend yield of 2.4%. Cabot’s dividend payout ratio (DPR) is 29.95%.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. AQR Capital Management LLC raised its position in Cabot by 123.0% in the second quarter. AQR Capital Management LLC now owns 867,946 shares of the specialty chemicals company’s stock worth $65,096,000 after acquiring an additional 478,702 shares in the last quarter. UBS Group AG raised its holdings in shares of Cabot by 186.7% in the 3rd quarter. UBS Group AG now owns 593,510 shares of the specialty chemicals company’s stock worth $45,136,000 after purchasing an additional 386,514 shares in the last quarter. Goldman Sachs Group Inc. raised its holdings in shares of Cabot by 32.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 442,646 shares of the specialty chemicals company’s stock worth $36,802,000 after purchasing an additional 108,645 shares in the last quarter. Barclays PLC lifted its stake in Cabot by 60.6% during the third quarter. Barclays PLC now owns 267,989 shares of the specialty chemicals company’s stock valued at $20,381,000 after purchasing an additional 101,168 shares during the last quarter. Finally, Man Group plc boosted its holdings in Cabot by 28.2% during the second quarter. Man Group plc now owns 340,823 shares of the specialty chemicals company’s stock worth $25,562,000 after buying an additional 74,918 shares in the last quarter. 93.18% of the stock is owned by institutional investors and hedge funds.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.